The functional polymorphism 844 A>G in Fc αRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility

Journal of Rheumatology

Volumn 38, Issue 3, 2011, Pages 446-449

  Broen, Jasper C A ^a   Coenen, Marieke J H ^a   Rueda, Blanca ^b   Witte, Torsten ^c   Padyukov, Leonid ^d   Klareskog, Lars ^d   Hesselstrand, Roger ^e   Wuttge, Dirk M ^e   Simeon, Carmen ^f   Ortego Centeno, Norberto ^g   González Gay, Miguel A ^h   Pros, Anna ⁱ   Hunzelman, Nicholas ^j   Riemekasten, Gabriela ^k   Kreuter, Alexander ^l   Vonk, Madelon ^a   Scorza, Rafaella ^m   Beretta, Lorenzo ^m   Airò, Paulo ⁿ   Van Riel, Piet L C M ^a   Kimberly, Robert ^o   Martin, Javier ^b   Edberg, Jeffrey ^o   Radstake, Timothy R D J ^a   more..

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^h HOSPITAL XERAL CALDE   (Spain)

ⁱ HOSPITAL DEL MAR   (Spain)

^j UNIVERSITY OF COLOGNE   (Germany)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^l RUHR UNIVERSITY BOCHUM   (Germany)

^m IRCCS   (Italy)

ⁿ SPEDALI CIVILI   (Italy)

^o The University of Alabama at Birmingham   (United States)

more..

Author keywords

CD89; Fc RI; IgA; Rheumatoid arthritis; Systemic sclerosis

Indexed keywords

ADENINE; CENTROMERE ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FC ALPHA RECEPTOR I; FC RECEPTOR; GUANINE; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PYROSEQUENCING; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS;

AGED; ANTIGENS, CD; ARTHRITIS, RHEUMATOID; EUROPE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; META-ANALYSIS AS TOPIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, FC; SCLERODERMA, SYSTEMIC;

EID: 79952395833     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100427     Document Type: Article

References (17)

1. Bournazos S, Woof JM, Hart SP, Dransfield I. Functional and clinical consequences of Fc receptor polymorphic and copy number variants. Clin Exp Immunol 2009;157:244-54.
2. Wines BD, Hogarth PM. IgA receptors in health and disease. Tissue Antigens 2006;68:103-14. (Pubitemid 44392318)
3. Otten MA, van Egmond M. The Fc receptor for IgA (Fc alpha RI, CD89). Immunol Lett 2004;92:23-31.
4. Jasek M, Manczak M, Sawaryn A, Obojski A, Wisniewski A, Luszczek W, et al. A novel polymorphism in the cytoplasmic region of the human immunoglobulin A Fc receptor gene. Eur J Immunogenet 2004;31:59-62. (Pubitemid 38580922)
5. Wu J, Ji C, Xie F, Langefeld CD, Qian K, Gibson AW, et al. Fc alpha RI (CD89) alleles determine the proinflammatory potential of serum IgA. J Immunol 2007;178:3973-82. (Pubitemid 46417668)
6. Snir O, Widhe M, von Spee SC, Lindberg J, Padyukov L, Lundberg K, et al. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann Rheum Dis 2009;68:736-43.
7. Verheijen R, de Jong BA, van Venrooij WJ. A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA anti-topo I autoantibodies in human sera. Clin Exp Immunol 1992;89:456-60.
8. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
9. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5. (Pubitemid 18073738)
10. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
11. Edberg JC, Wu J, Langefeld CD, Brown EE, Marion MC, McGwin G Jr, et al. Genetic variation in the CRP promoter: association with systemic lupus erythematosus. Hum Mol Genet 2008;17:1147-55. (Pubitemid 351494186)
12. Ji JD, Lee WJ, Kong KA, Woo JH, Choi SJ, Lee YH, et al. Association of STAT4 polymorphism with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 2010;37:141-7.
13. Rueda B, Broen J, Simeon C, Hesselstrand R, Diaz B, Suarez H, et al. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Hum Mol Genet 2009;18:2071-7.
14. Conley ME, Koopman WJ. Serum IgA1 and IgA2 in normal adults and patients with systemic lupus erythematosus and hepatic disease. Clin Immunol Immunopathol 1983;26:390-7. (Pubitemid 13147915)
15. Svard A, Kastbom A, Reckner-Olsson A, Skogh T. Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project. Arthritis Res Ther 2008;10:R75.
16. Martínez-Cordero E, Trejo AP, León DE. IgM, IgG, and IgA anti-DNA topoisomerase I antibodies in systemic sclerosis. J Clin Lab Anal 2009;23:408-16.
17. Luigi Meroni P, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010;69:1420-2.